Highnoon Featured in Forbes Asia’s 200 Best Under a Billion 2022

Highnoon has been featured in the prestigious Forbes Asia’s 200 Best Under a Billion list once again. It is the third time in four years that the company has been recognized for its composite rating, which considers factors like revenue, profit growth, low debt levels, and strong governance.
The best-performing 200 companies are selected from a pool of 24,000 companies in the Asia-Pacific region.
‘We are delighted to stand among the success stories of the Asia-Pacific region for the third time,’ said Tausif Khan, Highnoon’s Chairman, on this achievement. He further commented, ‘We dedicate this accomplishment to the individuals of our company who do their best to be the best. We remain thankful to the health care professionals for their confidence, and we value our business partners for the enabling. We will continue to focus on providing products that enrich life by improving clinical outcomes.’
This success has made headlines in multiple news sources.


Business Recorder

News Curators


MG Link